Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EHMT2 | Q96KQ7 | 3/20 | 0.46 |
| ▸ | GALR1 | P47211 | 7/20 | 0.46 |
| ▸ | GALR2 | O43603 | 6/20 | 0.46 |
| ▸ | BCL6 | P41182 | 2/20 | 0.42 |
| ▸ | IDH2 | P48735 | 1/20 | 0.40 |
| ▸ | FGFR3 | P22607 | 2/20 | 0.40 |
| ▸ | CDK1 | P06493 | 1/20 | 0.39 |
| ▸ | CDK4 | P11802 | 1/20 | 0.39 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.39 |
| ▸ | CCND1 | P24385 | 1/20 | 0.39 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.39 |
| ▸ | CDK2 | P24941 | 1/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | EHMT1 | Q9H9B1 | 2/20 | 0.38 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6016904 | 0.89 | BCL6 (0.48) | EHMT2BCL6 | |
| SCHEMBL6642163 | 0.89 | EHMT2 (0.46) | EHMT2BCL6IDH2FGFR3EHMT1 | |
| Hydrochloric Acid SCHEMBL6611427 | 0.88 | EHMT2 (0.46) | EHMT2BCL6IDH2FGFR3EHMT1 | |
| SCHEMBL4839396 | 0.88 | GALR1 (0.47) | GALR1GALR2BCL6CDK1CDK4 | |
| Hydrochloric Acid SCHEMBL6611422 | 0.87 | EHMT2 (0.45) | EHMT2BCL6IDH2FGFR3CDK2 | |
| SCHEMBL4836074 | 0.87 | EHMT2 (0.49) | EHMT2GALR1GALR2BCL6FGFR3 | |
| SCHEMBL4829436 | 0.83 | EHMT2 (0.50) | EHMT2GALR1GALR2BCL6IDH2 | |
| SCHEMBL6856715 | 0.83 | EHMT2 (0.54) | EHMT2GALR1GALR2BCL6IDH2 | |
| Hydrochloric Acid SCHEMBL5550552 | 0.82 | EHMT2 (0.49) | EHMT2GALR1GALR2BCL6IDH2 | |
| Bromide SCHEMBL6016985 | 0.82 | EHMT2 (0.49) | EHMT2GALR1GALR2BCL6IDH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040077648-A1 | Methods and compositions of novel triazine compounds | DR. REDDY'S LABORATORIES LTD. (IN) | 2004-04-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040077648-A1 | Methods and compositions of novel triazine compounds | AREG, TGFB1, PTGIS | EHMT2 2905/4885GALR1 961/4885GALR2 668/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.